- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Beryl Drugs has announced the closure of its trading window for Board Members, Promoters, and designated persons. The window closed on April 1st and will remain shut until 48 hours after the company declares its Audited Financial Results for the year ended March 31st. This measure is in line with the company's code of conduct to regulate insider trading, ensuring fair disclosure. The date for the Board Meeting to approve these financial results will be announced soon, preventing unauthorized trading before key financial information is public.